Formation and propagation of tau oligomeric seeds

被引:96
作者
Gerson, Julia E. [1 ,2 ,3 ]
Kayed, Rakez [1 ,2 ,3 ]
机构
[1] Univ Texas Med Branch, George P & Cynthia Woods Mitchell Ctr Neurodegene, Galveston, TX 77555 USA
[2] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA
[3] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA
关键词
tauopathies; tau oligomers; oligomeric seeding; propagation of tau pathology; Alzheimer's;
D O I
10.3389/fneur.2013.00093
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Tau misfolding and aggregation leads to the formation of neurofibrillary tangles (NFTs), which have long been considered one of the main pathological hallmarks for numerous neurodegenerative diseases known as tauopathies, including Alzheimer's Disease (AD) and Parkinson's Disease (PD). However, recent studies completed both in vitro and in vivo suggest that intermediate forms of tau, known as tau oligomers, between the monomeric form and NFTs are the true toxic species in disease and the best targets for anti-tau therapies. However, the exact mechanism by which the spread of pathology occurs is unknown. Evidence suggests that tau oligomers may act as templates for the misfolding of native tau, thereby seeding the spread of the toxic forms of the protein. Recently, researchers have reported the ability of tau oligomers to enter and exit cells, propagating from disease affected regions to unaffected areas. While the mechanism by which the spreading of misfolded tau occurs has yet to be elucidated, there are a few different models which have been proposed, including cell membrane stress and pore-formation, endocytosis and exocytosis, and non-traditional secretion of protein not enclosed by a membrane. Coming to an understanding of how toxic tau species seed and spread through the brain will be crucial to finding effective treatments for neurodegenerative tauopathies.
引用
收藏
页数:10
相关论文
共 138 条
[1]   Early events in the fibrillation of monomeric insulin [J].
Ahmad, A ;
Uversky, VN ;
Hong, D ;
Fink, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (52) :42669-42675
[2]   NMNAT suppresses Tau-induced neurodegeneration by promoting clearance of hyperphosphorylated Tau oligomers in a Drosophila model of tauopathy [J].
Ali, Yousuf O. ;
Ruan, Kai ;
Zhai, R. Grace .
HUMAN MOLECULAR GENETICS, 2012, 21 (02) :237-250
[3]  
Alonso AD, 2001, J BIOL CHEM, V276, P37967
[4]   Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments [J].
Alonso, AD ;
Zaidi, T ;
Novak, M ;
Grundke-Iqbal, I ;
Iqbal, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (12) :6923-6928
[5]   Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms [J].
Andorfer, C ;
Kress, Y ;
Espinoza, M ;
de Silva, R ;
Tucker, KL ;
Barde, YA ;
Duff, K ;
Davies, P .
JOURNAL OF NEUROCHEMISTRY, 2003, 86 (03) :582-590
[6]   Tau dephosphorylation at tau-1 site correlates with its association to cell membrane [J].
Arrasate, M ;
Pérez, M ;
Avila, J .
NEUROCHEMICAL RESEARCH, 2000, 25 (01) :43-50
[7]   Role of tau protein in both physiological and pathological conditions [J].
Avila, J ;
Lucas, JJ ;
Pérez, M ;
Hernández, F .
PHYSIOLOGICAL REVIEWS, 2004, 84 (02) :361-384
[8]   Tau-mediated neurodegeneration in Alzheimer's disease and related disorders [J].
Ballatore, Carlo ;
Lee, Virginia M. -Y. ;
Trojanowski, John Q. .
NATURE REVIEWS NEUROSCIENCE, 2007, 8 (09) :663-672
[9]   Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias [J].
Barghorn, S ;
Zheng-Fischhöfer, Q ;
Ackmann, M ;
Biernat, J ;
von Bergen, M ;
Mandelkow, EM ;
Mandelkow, E .
BIOCHEMISTRY, 2000, 39 (38) :11714-11721
[10]   Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments [J].
Barghorn, S ;
Mandelkow, E .
BIOCHEMISTRY, 2002, 41 (50) :14885-14896